{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-233294","form_type":"8-K","ticker":"CABA","cik":"0001759138","company_name":"Cabaletta Bio, Inc.","filed_at":"2024-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.498749+00:00","generated_at":"2026-05-30T19:22:30.429713+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cabaletta Bio provides updated clinical milestones: RESET data at ACR 2024, MG data H1 2025","bullets":["Additional clinical data from RESET-SLE and RESET-Myositis trials to be presented at ACR Convergence 2024 in November.","Initial clinical data from the RESET-SSc trial also scheduled for ACR Convergence 2024.","Initial clinical data from the RESET-MG trial anticipated in the first half of 2025.","Updated corporate presentation posted on the company website with these milestones."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-233294","json":"https://secwatch.observer/filing/0001193125-24-233294.json","markdown":"https://secwatch.observer/filing/0001193125-24-233294.md","text":"https://secwatch.observer/filing/0001193125-24-233294.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759138/000119312524233294/0001193125-24-233294-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759138/000119312524233294/d899909d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T19:22:30.429713+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}